Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by independent educational grants from Astellas Pharma Global Development, Inc., Celgene Corporation, and Jazz Pharmaceuticals.

Managing the Continuum of Myeloid Malignancies (CML, MPN, MDS, and AML)

Andrew Artz, MS, MD
University of Chicago Medicine

Jean A. Ridgeway, DNP, APN, NP-C, AOCN®
University of Chicago Medicine

Take a deep dive into the updated WHO criteria for diagnosing myeloid malignancies, the mechanisms of action of new novel therapies, and the growing role of molecular mutations, while also learning how to take a collaborative, multidisciplinary approach to classifying these diseases. Advanced practitioners are key to managing the evolving continuum of myeloid malignancies and creating a multidisciplinary team approach to managing patients with complex myeloid malignancies.



 

Download Podcast

   To claim credit for podcast click here
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

   To claim credit for the slides & transcript click here





These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here